Post-Conference Speaker :
Mark O. Goodarzi, MD, PhD

Director, Division of Endocrinology, Diabetes and Metabolism
Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Mark O. Goodarzi, MD, PhD focuses his research efforts on identification of genetic factors underlying conditions related to insulin resistance and the metabolic syndrome, using population-based approaches. Major focus areas include the role of the gut microbiome in insulin resistance and insulin secretion, elucidation of genetic determinants of insulin clearance, insulin resistance and atherosclerosis in Hispanics, genetics studies in the polycystic ovary syndrome, and pharmacogenetics of the glycemic response to statins. Another research effort is characterization of the pathophysiology and genetics of pancreatogenic diabetes within the NIH-funded Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer.

Dr. Goodarzi is the Director of the Division of Endocrinology, Diabetes and Metabolism and Professor of Medicine at Cedars-Sinai Medical Center (CSMC) where he holds the Eris M. Field Chair in Diabetes Research. Dr. Goodarzi’s contributions were recognized by the Endocrine Society’s Richard E. Weitzman Memorial Award.


Send Email for Mark Goodarzi